Rexall Sundown merger talks with Twinlab disclosed July 1.
This article was originally published in The Tan Sheet
Executive Summary
REXALL SUNDOWN MERGER TALKS WITH TWINLAB were disclosed by the companies July 1. Rexall and Twinlab Corp. "are engaged in substantive discussions relating to a potential merger, which would contemplate that Rexall Sundown would issue .74 shares of its common stock for each outstanding share of Twinlab common stock," the companies said. The proposed combination of the two companies would be structured as a pooling of interests and would be accretive to earnings.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning